FDA inspection
GC Biopharma Corp_Ochang Plant: FDA inspection ending Apr 28, 2023
FDA inspection 1210455 · Voluntary Action Indicated (VAI) · Cheongju
Key facts
| Inspection ID | 1210455 |
|---|---|
| Firm | GC Biopharma Corp_Ochang Plant |
| FEI number | 3009561235 |
| Address | 586 Gwahaksaneob2-Ro; Cheongwon |
| City | Cheongju |
| Fiscal year | 2023 |
| Inspection end date | Apr 28, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Blood and Blood Products |
| Product type | Biologics |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data